Clinical Trial Update: Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

A University of Illinois at Chicago-led trial investigating lycopene for prostate cancer and benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostate Cancer

Drugs mentioned

• Lycopene (lycopene)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Nonmalignant Neoplasm, Prostate Cancer | NA | Status: COMPLETED